A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC



Status:Recruiting
Conditions:Lung Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/3/2019
Start Date:April 14, 2017
End Date:February 1, 2024
Contact:Pfizer CT.gov Call Center
Email:ClinicalTrials.gov_Inquiries@pfizer.com
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF LORLATINIB (PF-06463922) MONOTHERAPY VERSUS CRIZOTINIB MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER

A phase 3 study to demonstrate whether lorlatinib given as monotherapy is superior to
crizotinib alone in prolonging the progression-free survival in advanced ALK-positive NSCLC
patients who are treatment naïve and to compare lorlatinib to crizotinib with respect to
overall survival in the same population


Inclusion Criteria:

- Histologically or cytologically confirmed diagnosis of locally advanced or metastatic
ALK-positive NSCLC; at least 1 extracranial measurable target lesion not previously
irradiated. CNS metastases allowed if asymptomatic and not currently requiring
corticosteroid treatment.

- Availability of an archival FFPE tissue specimen.

- No prior systemic NSCLC treatment.

- ECOG PS 0, 1, or 2.

- Age ≥18 years .

- Adequate Bone Marrow, Liver, Renal, Pancreatic Function

- Negative pregnancy test for females of childbearing potential

Exclusion Criteria:

- Spinal cord compression unless good pain control attained

- Major surgery within 4 weeks prior to randomization.

- Radiation therapy within 2 weeks prior to randomization, including stereotactic or
partial brain irradiation. Whole brain irradiation within 4 weeks prior to
randomization

- Active bacterial, fungal, or viral infection

- Clinically significant cardiovascular disease, active or within 3 months prior to
enrollment. Ongoing cardiac dysrhythmias, uncontrolled atrial fibrillation,
bradycardia or congenital long QT syndrome

- Predisposing characteristics for acute pancreatitis in the last month prior to
randomization.

- History of extensive, disseminated, bilateral or presence of Grade 3 or 4 interstitial
fibrosis or interstitial lung disease

- Active malignancy (other than NSCLC, non melanoma skin cancer, in situ cervical
cancer, papillary thyroid cancer, LCIS/DCIS of the breast, or localized prostate
cancer) within the last 3 years prior to randomization.

- Concurrent use of any of the following food or drugs within 12 days prior to the first
dose of lorlatinib or crizotinib.

1. known strong CYP3A inhibitors .

2. known strong CYP3A inducers

3. known P gp substrates with a narrow therapeutic index

- Concurrent use of CYP3A substrates with narrow therapeutic indices within 12 days
prior to the first dose of lorlatinib or crizotinib.

- Other severe acute or chronic medical or psychiatric condition, including recent or
active suicidal ideation or behavior, or laboratory abnormality that may increase the
risk associated with study participation or interfere with the interpretation of study
results

- Investigational site staff members directly involved in the conduct of the study and
their family members, or Pfizer employees, including their family members, directly
involved in the conduct of the study.

- Participation in other studies involving investigational drug(s) within 2 weeks prior
to study entry and/or during study participation.
We found this trial at
34
sites
1959 NE Pacific St
Seattle, Washington 98195
(206) 598-3300
University of Washington Medical Center University of Washington Medical Center is one of the nation's...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials
825 Eastlake Ave E
Seattle, Washington 98109
(206) 288-7222
Seattle Cancer Care Alliance Seattle Cancer Care Alliance (SCCA) is a cancer treatment center that...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Aliso Viejo, CA
Click here to add this to my saved trials
601 East Altamonte Drive
Altamonte Springs, Florida 32701
?
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
243 Charles St
Boston, Massachusetts 02114
(617) 523-7900
Massachusetts Eye & Ear Infirmary Whether you see our physicians at Mass. Eye and Ear's...
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02114
?
mi
from
Boston, MA
Click here to add this to my saved trials
1 Joslin Place
Boston, Massachusetts 02215
?
mi
from
Boston, MA
Click here to add this to my saved trials
403 South Kings Avenue
Brandon, Florida 33511
?
mi
from
Brandon, FL
Click here to add this to my saved trials
3280 McMullen Booth Road
Clearwater, Florida 33761
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
Dickson, Tennessee 37055
?
mi
from
Dickson, TN
Click here to add this to my saved trials
Franklin, Tennessee 37067
?
mi
from
Franklin, TN
Click here to add this to my saved trials
Gainesville, Florida
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gallatin, Tennessee 37066
?
mi
from
Gallatin, TN
Click here to add this to my saved trials
Hermitage, Tennessee 37076
?
mi
from
Hermitage, TN
Click here to add this to my saved trials
1301 2nd Avenue Southwest
Largo, Florida 33770
?
mi
from
Largo, FL
Click here to add this to my saved trials
Lebanon, Tennessee 37087
?
mi
from
Lebanon, TN
Click here to add this to my saved trials
521 North Lecanto Highway
Lecanto, Florida 34461
?
mi
from
Lecanto, FL
Click here to add this to my saved trials
Murfreesboro, Tennessee 37130
?
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
250 25th Ave N, Ste 100
Nashville, Tennessee 37023
615-320-5090
Tennessee Oncology, PLLC Since 1976 Tennessee Oncology has been providing quality cancer care. In 2013,...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
3322 West End Avenue
Nashville, Tennessee 37203
(615)329-SCRI (7274)
Sarah Cannon Research Institute Sarah Cannon Research Institute (SCRI) is a global strategic research organization...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
New Port Richey, Florida 34655
?
mi
from
New Port Richey, FL
Click here to add this to my saved trials
1630 Southeast 18th Street
Ocala, Florida 34471
?
mi
from
Ocala, FL
Click here to add this to my saved trials
765 Image Way
Orange City, Florida 32763
?
mi
from
Orange City, FL
Click here to add this to my saved trials
Orlando, Florida 32806
?
mi
from
Orlando, FL
Click here to add this to my saved trials
1115 Avenida de Mayo
Pergamino, Buenos Aires
?
mi
from
Pergamino,
Click here to add this to my saved trials
Saint Petersburg, Florida 33705
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Shelbyville, Tennessee 37160
?
mi
from
Shelbyville, TN
Click here to add this to my saved trials
Smyrna, Tennessee 37167
?
mi
from
Smyrna, TN
Click here to add this to my saved trials
Spring Hill, Florida 34608
?
mi
from
Spring Hill, FL
Click here to add this to my saved trials
3402 West Doctor Martin Luther King Junior Boulevard
Tampa, Florida 33607
?
mi
from
Tampa, FL
Click here to add this to my saved trials
4100 Waterman Way
Tavares, Florida 32778
?
mi
from
Tavares, FL
Click here to add this to my saved trials
1400 U.S. 441
The Villages, Florida 32159
?
mi
from
The Villages, FL
Click here to add this to my saved trials
2100 Glenwood Drive
Winter Park, Florida 32792
?
mi
from
Winter Park, FL
Click here to add this to my saved trials